Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

3rd EurocanPlatform Translational Research Course /
Functional characterisation of therapeutic targets through comparative pharmacology

12th - 16th Oct 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.12.15
Views: 1970
Rating:

Dr Igor Vivanco - Institute Of Cancer Research, London, UK

Dr Vivanco talks to ecancer at the 3rd EurocanPlatform Translational Research Course about how researchers are trying to determine the basic mechanism of how targeted drugs elicit the response they have in cancer cells. He also discusses comparative pharmacology: the detailed comparison and characterization of multiple selective pharmacological agents of a defined target with distinct mechanisms of action.

He describes how they’re currently trying to work on a number of Phase I clinical trials and learn why most trials tend to fail, as well as his work on the response to EGFR inhibitors in EGFR-mutant glioblastoma.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation